Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Tempest Therapeutics, Inc. (OVAS)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Net income  -35.7-28.3-19.2-44.6-27.2-51.0-82.3-73.2
Depreciation and amortization   [+]0.60.40.30.10.01.72.21.3
Asset impairment charges       0.42.1 
Stock-based compensation  1.61.10.54.31.46.99.219.3
Change in working capital   [+]11.09.66.0-0.91.0-4.74.6-0.5
Other operating activities  -8.5-8.7-6.6-0.21.11.22.42.8
Cash from operations  -31.1-26.0-19.0-41.2-23.6-45.6-61.7-50.3
   
Capital expenditures  -0.6-0.1-0.1-0.40.0-0.2-2.6-5.2
Acquisitions      -0.5   
Purchases of short-term investments, net     4.42.518.9-10.7-41.7
Other cash from investing   0.00.0  -1.521.58.6
Cash from investing  -0.6-0.10.04.01.917.38.3-38.3
   
Issuance of common stock, net  8.933.4 26.738.8 53.9124.1
Option exercises   0.10.1     
Financing costs   -0.1  -1.4   
Other cash from financing  2.525.734.70.337.6 0.21.3
Cash from financing  11.459.134.626.977.70.054.1125.4
   
Free cash flow  -31.6-26.1-19.1-41.6-23.7-45.7-64.3-55.5
        Per share (diluted)  ($2.74)($6.88)($40.73)($3.04)($15.31)($1.28)($2.00)($2.05)
   
Cash paid for interest  1.51.0      
Cash paid for income taxes  0.0   0.0   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy